ArticleGenes2022

A Clinical Investigation on the Theragnostic Effect of MicroRNA Biomarkers for Survival Outcome in Cervical Cancer: A PRISMA-P Compliant Protocol for Systematic Review and Comprehensive Meta-Analysis.

Peter Shaw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.